1 |
Cardoneanu A, Cozma S, Rezus C, Petrariu F, Burlui AM, Rezus E. Characteristics of the intestinal microbiome in ankylosing spondylitis. Exp Ther Med 2021;22:676. [PMID: 33986841 DOI: 10.3892/etm.2021.10108] [Reference Citation Analysis]
|
2 |
Schaeverbeke T, Truchetet ME, Richez C. Gut metagenome and spondyloarthritis. Joint Bone Spine 2013;80:349-52. [PMID: 23806346 DOI: 10.1016/j.jbspin.2013.02.005] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
|
3 |
Berman R, Kopf KW, Min E, Huang J, Downey GP, Alam R, Chu HW, Day BJ. IL-33/ST2 signaling modulates Afghanistan particulate matter induced airway hyperresponsiveness in mice. Toxicol Appl Pharmacol 2020;404:115186. [PMID: 32777237 DOI: 10.1016/j.taap.2020.115186] [Reference Citation Analysis]
|
4 |
Manasson J, Scher JU. Spondyloarthritis and the microbiome: new insights from an ancient hypothesis. Curr Rheumatol Rep 2015;17:10. [PMID: 25663180 DOI: 10.1007/s11926-014-0487-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
|
5 |
Cypers H, Bridges SL, Elewaut D. Spondyloarthritis. In: Ragab G, Atkinson TP, Stoll ML, editors. The Microbiome in Rheumatic Diseases and Infection. Cham: Springer International Publishing; 2018. pp. 201-20. [DOI: 10.1007/978-3-319-79026-8_16] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
6 |
Zhang L, Hu Y, Xu Y, Li P, Ma H, Li X, Li M. The correlation between intestinal dysbiosis and the development of ankylosing spondylitis. Microb Pathog 2019;132:188-92. [PMID: 31039390 DOI: 10.1016/j.micpath.2019.04.038] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|